ClinicalTrials.gg
RecruitingNCT06620900ExpandAccessUpdated Nov 18, 2026

Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance Use

An interventional study of Integrated Model of Care in Concussion, Mild Traumatic Brain Injury, Brain Injury and Traumatic Brain Injury, sponsored by Shepherd Center, Atlanta GA. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Shepherd Center, Atlanta GA · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.
Updated Nov 18, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 420 studies in Brain Concussion with a site in United States — 102 open to participants now, 123 under way, 5 of them phase 3. Brain Concussion · United States.

Planned enrollment
29th of 323
360 · median 60
Started
2025
with 26 others
No phase
265 of 420
63 open now
Primary completion
2028-08
later than 96 of 122 live
Registered
365th of 420
by date

Among the 420 studies in Brain Concussion with a site in United States, this one is the 29th largest by planned enrollment of the 323 interventional ones that give a count, is one of 27 that started in 2025, is one of 265 with no phase, reaches primary completion later than 96 of the 122 other live ones, and was the 365th registered.

Brain Concussion

641 studies on the registry are indexed under Brain Concussion; 167 are open to participants now.

Browse Brain Concussion studies →

Open to participants now

102 of the 420 studies in Brain Concussion with a site in United States are open now. Recruiting first, the newest first:

97 more — sign in →

All 102 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 114 Brain Concussion studies recruiting now, 34 (30%) set no upper age limit and 73 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 420 studies in Brain Concussion with a site in United States, or all of them as a file.
02

Study summary

The purpose of this research is to determine whether military veterans and service members with mild traumatic brain injury with and without co-occurring substance use can complete and benefit from integrated interdisciplinary care individualized to their symptoms, goals, and needs.

Participants will complete surveys about substance use and other symptoms at the beginning and end of treatment in an intensive outpatient program and 6 months after discharge.

Read the detailed description

This pragmatic clinical trial will (1) assess treatment retention and treatment outcomes at the completion of interdisciplinary intensive outpatient program (IOP) and at a 6-month follow-up comparing service members and veterans (SM/Vs) with mild traumatic brain injury (mTBI) + substance use (SU) and a TBI -control group; and (2) assess SU-related outcomes at the end of IOP treatment and durability of SU outcomes at 6-months follow-up among SM/Vs with co-occurring SU. Analyses of these key treatment outcomes along with input from lived experience consultants and other key stakeholders, will be used to refine and disseminate a scalable approach to treating individuals with mTBI and co-occurring SU.

03

Conditions studied

  • Concussion, Mild Traumatic Brain Injury
  • Brain Injury
  • Traumatic Brain Injury
  • Substance Use
  • Substance Use Disorder (SUD)

Keywords

  • Concussion
  • Mild Traumatic Brain Injuty
  • Brain Injury
  • Substance use
  • Substance Use Disorder
  • Military
  • Service Members
  • Veterance
  • Interdisciplinary
  • Intensive Outpatient Program
  • Neurorehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years of age
  • US military service member or veteran
  • Diagnosis of mild traumatic brain injury (mTBI) and/or repetitive head impact/blast exposures
  • Participating in the SHARE Military Initiative intensive outpatient program

Exclusion criteria

Exclusion Criteria:

  • History of brain injury other than mTBI or progressive neurological disorder
  • Active psychosis
  • Not able to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
360 participants (estimated)

Study arms

  • Experimental
    Integrated Model of Care

    Participants will engage in interdisciplinary intensive outpatient program (IOP) treatment for mild traumatic brain injury with individualized support for substance use (SU) following which they will receive support for SU in the transition support program.

    Other: Integrated Model of Care

Interventions

  • OtherIntegrated Model of Care

    The Integrated Model of Care was developed and piloted by the study team provide support for individuals seeking care in an interdisciplinary intensive outpatient program for mild traumatic brain injury to receive support for co-occurring substance use-related needs.

06

What researchers measure

Primary outcomes

  1. Neurobehavioral Symptom Inventory (NSI)

    a 22-item, self-report questionnaire used to measure change in symptoms commonly associated with mild traumatic brain injury over time

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

  2. Short Inventory of Problems- Revised (SIP-R)

    a 17-item self-report inventory used to assess adverse consequences of substance use

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

Secondary outcomes

  1. Life-Satisfaction Questionnaire -11 (LISAT-11)

    an internationally validated 11-item self-report inventory of satisfaction within important life domains: life as a whole, vocational situation, financial situation, leisure situation, contacts with friends, sexual life, self-care management, family life, partner, physical health, and psychological health

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

  2. Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    a 20-item self-report inventory used to assess severity of posttraumatic stress symptoms and monitoring symptom change during and after treatment

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

  3. Patient Health Questionnaire (PHQ-8)

    an eight item, self-report inventory used to screen for the presence and severity of depression

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

  4. Generalized Anxiety Disorder Scale (GAD-7)

    a seven item, self-report inventory used to screen for the presence and severity of anxiety

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

  5. Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS Update)

    a multi-item, multi-subtest, clinician administered objective assessment used to measure change over time in neuropsychological status by yielding a Total Score, as well as Immediate Memory, Delayed Memory, Attention, Language, and Visuospatial/ Constructional scores

    Time frame: Study enrollment and immediately after the intervention

  6. Sensory Organization Test (SOT)

    completed as part of quantitative Balance Testing (Bertec) which provides information about postural stability by measuring subject sway on a force platform under different sensory conditions; the SOT is used to evaluate sensory weighting in postural control using a series of conditions of increased difficulty.

    Time frame: Study enrollment and immediately after the intervention

  7. Behavior Rating Inventory of Executive Functioning - Adult Version (BRIEF-A)

    a 75-item self-report inventory of executive functioning in everyday environments that yields a total Global Executive Composite score as well as a Behavioral Regulation Index and Metacognitive Index

    Time frame: Study enrollment and immediately after the intervention

  8. Alcohol Use Disorders Identification Test- Concise (AUDIT-C)

    a three-item, self-report screening tool used to identify people who with active alcohol use disorders (including alcohol abuse or dependence).

    Time frame: Study enrollment and at 6 months follow-up

  9. Drug Abuse Screening Test (DAST-10)

    a 10-item self-report instrument that yields a quantitative index of the degree of consequences related to drug use

    Time frame: Study enrollment and at 6 months follow-up

  10. Cannabis Use Disorder Identification Test (CUDIT-R)

    an 8-item measure designed for screening for problematic cannabis use and use a brief repeated outcome measure

    Time frame: Study enrollment and at 6 months follow-up

  11. National Survey on Drug Use and Health (NSDUH)- 30-day use: Alcohol and Substances

    survey of alcohol use (tallying days used and estimating average number of drinks per drinking day) and additional substances used (number of days used)

    Time frame: Study enrollment, immediately after the intervention, and at 6 months follow-up

07

Study locations

1 of 1 sites recruiting
  • Shepherd Center
    Atlanta, Georgia 30309, United States
    Recruiting
    • Katherine L McCauley, PhD · Contactkatherine.mccauley@shepherd.org · 404-603-4980
    • Russell K Gore, MD · Principal investigator
    • Katherine L McCauley, PhD · Sub investigator
    • Tracey D Wallace, MS · Sub investigator
08

References and documents

Publications

  • Wallace TD, McCauley KL, Hodge AT, Moran TP, Porter ST, Whaley MC, Gore RK. Use of person-centered goals to direct interdisciplinary care for military service members and Veterans with chronic mTBI and co-occurring psychological conditions. Front Neurol. 2022 Nov 16;13:1015591. doi: 10.3389/fneur.2022.1015591. eCollection 2022. PubMed 36523344 ↗

Related links

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — We will submit de-identified research data into the Federal Interagency TBI Research (FITBIR) Informatics System at the completion of the clinical trial. The following data will be collected and reported the following National Institute of Neurological Disorders and Stroke (NINDS) TBI common data elements (CDE) as part of this process: Demographics and Injury Characteristics Neurobehavioral Symptom Inventory (NSI) Alcohol Use Disorders Identification Test-Concise (AUDIT-C) Patient Health Questionnaire (8 Item) (PHQ-8) Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Life-Satisfaction Questionnaire -11 (LISAT-11) Sensory Organization Test (SOT) Short Inventory of Problems- Revised (SIP-R) Drug Abuse Screening Test (DAST-10) Cannabis Use Disorder Identification Test (CUDIT-R) National Survey on Drug Use and Health (NSDUH)- 30-day use: Alcohol and Substances

Time frame: We will complete upload of IPD by Aug 31, 2025.

Access criteria: Researchers can then file an application with FITBIR, following FITBIR processes and protocols, to request access to the data for research purposes.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Aug 2028, 41 months after the start.

Of 249 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 41 months is above that.

Counting every sponsor, half of 265 studies reached it within 28 months; a quarter within 19 and three quarters within 47.

Start moved once since we started tracking on Sep 25, 2026: Feb 2025 → Mar 2025, on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2024
First posted
Oct 1, 2024
StartActual
Mar 24, 2025was Feb 2025
Primary completionEst.
Aug 2028
CompletionEst.
Aug 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Shepherd Center is now Recruiting
Nov 18, 2026
Start date
Feb 2025→Mar 24, 2025 (actual)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Shepherd Center is now Recruiting
    Start date Feb 2025→Mar 24, 2025 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06620900
Lead sponsor
Shepherd Center, Atlanta GA
Responsible party
Sponsor
First posted
Oct 1, 2024
Start date
Mar 24, 2025
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Russell K Gore, MD
Contact
russell.gore@shepherd.org
404-603-4980

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion